Cargando…
Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
BACKGROUND: Ankylosing spondylitis (AS) is an inflammatory disease with documented elevated cardiovascular (CV) risk due to systemic inflammation and a higher prevalence of CV risk factors. CV risk management (CV-RM) could be an effective method to reduce CV mortality and morbidity in AS patients. W...
Autores principales: | Heslinga, Sjoerd C, Van den Oever, Inge A, Van Sijl, Alper M, Peters, Mike J, Van der Horst-Bruinsma, Irene E, Smulders, Yvo M, Nurmohamed, Michael T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404047/ https://www.ncbi.nlm.nih.gov/pubmed/25886634 http://dx.doi.org/10.1186/s12891-015-0532-3 |
Ejemplares similares
-
The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients—The CARDAS Study
por: Baniaamam, Milad, et al.
Publicado: (2021) -
The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
por: Heslinga, SC, et al.
Publicado: (2018) -
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
por: Swart, I. A. P., et al.
Publicado: (2022) -
Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation
por: Baniaamam, M., et al.
Publicado: (2021) -
Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients
por: Blanken, Annelies B., et al.
Publicado: (2022)